DOI: 10.1309/AJCPQ4N7BRZQVHAL
175
175
AJCP / Editorial
References
1. Katayev A, Balciza C, Seccombe D. Establishing reference
intervals for clinical laboratory test results: is there a better
way? Am J Clin Pathol. 2010;133:180-186.
2. Clinical and Laboratory Standards Institute. Defining,
Establishing, and Verifying Reference Intervals in the Clinical
Laboratory; Approved Guideline. Third Edition. CLSI
document C28-A3. Wayne, PA: Clinical and Laboratory
Standards Institute; 2008.
3. Solberg HE. Approved recommendations (1987) on the
theory of reference values, part 5: statistical treatment of
collected reference values: determination of reference limits.
J Clin Chem Clin Biochem. 1987;25:645-656.
4. Horn PS, Pesce AJ. Reference Intervals: A Users Guide.
Washington, DC: AACC Press; 2005.
5. Hoffman RG. Statistics in the practice of medicine. JAMA.
1963;188:864-873.
6. Brewster LM, Mairuhu G, Sturk A, et al. Distribution of
creatine kinase in the general population: implications for
statin therapy. Am Heart J. 2007;154:655-661.
7. College of American Pathologists. 2010 Surveys & Anatomic
Pathology Education Programs [online catalog]. Reference
Range Services [page 101]. http://www.cap.org/apps/docs/
proficiency_testing/surveys_catalog/2010_surveys_catalog.
pdf. Accessed December 6, 2009.
8. Canadian External Quality Assessment Laboratory
(CEQAL). Proficiency Testing (PT) Samples for the
Measurement of Lipids. http://www.ceqal.com/services.php.
Accessed December 6, 2009.
9. College of American Pathologists. 2010 Surveys & Anatomic
Pathology Education Programs [online catalog]. Accuracy
Based Surveys [pages 85-88]. http://www.cap.org/apps/docs/
proficiency_testing/surveys_catalog/2010_surveys_catalog.
pdf. Accessed December 6, 2009.
10. Third Report of the National Cholesterol Education
Program (NCEP) Expert Panel on Detection, Evaluation,
and Treatment of High Blood Cholesterol in Adults
(Adult Treatment Panel III) Final Report. Circulation.
2002;106:3143-3421.
11. National Kidney Disease Education Program. Estimating and
reporting GFR. http://www.nkdep.nih.gov/labprofessionals/
estimate_report_gfr.htm. Accessed December 6, 2009.
12. National Kidney Disease Education Program. GFR MDRD
calculators for Adults (Conventional units). http://www.
nkdep.nih.gov/professionals/gfr_calculators/idms_con.htm.
Accessed December 6, 2009.
13. US Preventive Services Task Force. Screening for thyroid
disease: recommendation statement. Ann Intern Med.
2004;140:125-127.
14. Helfand M. Screening for subclinical thyroid dysfunction
in nonpregnant adults: a summary of the evidence for
the US Preventive Services Task Force. Ann Intern Med.
2004;140:128-141.
15. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid
disease: scientific review and guidelines for diagnosis and
management. JAMA. 2004;291:228-238.
16. Lin K, Lipsitz R, Miller T, et al. Benefits and harms of
prostate-specific antigen screening for prostate cancer: an
evidence update for the US Preventive Services Task Force.
Ann Intern Med. 2008;149:192-199.
17. Barry MJ. The PSA conundrum [editorial]. Arch Intern Med.
2006;166:7-8.
DOI: 10.1309/AJCPQ4N7BRZQVHAL
177
177